Document is current
Any future updates will be listed below
-
Authors
Besag, Frank M. C. https://orcid.org/0000-0002-4530-7933
Vasey, Michael J. https://orcid.org/0000-0003-1983-3531
Chin, Richard F. M. https://orcid.org/0000-0002-7256-3027
- License Information
-
More Information
Article History
Accepted: 29 June 2025
First Online: 4 October 2025
Declarations
:
: No funding was received in relation to the preparation of this manuscript.
: R.F.M.C. was a principal investigator in a GW Pharma sponsored trial of cannabidiol for the treatment of Lennox–Gastaut syndrome. He has received honoraria from, has provided paid consultation for, and has awarded educational grants from Jazz Pharmaceuticals and UCB. F.M.C.B. is an Editorial Board member of Pediatric Drugs. F.M.C.B. was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions. F.M.C.B. and M.J.V. have no competing interests to declare that are relevant to the topics covered in this article.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: All authors contributed to the drafting of the manuscript and approved the final version for submission.
